|
× |
 |
Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest: Findings From a Randomized, Double-Blind, Placebo-Controlled Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clinical Predictors of Response to Clozapine Treatment in Ambulatory Patients With Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: An Interim Analysis PDF |
$40.00 |
|
$40.00 |
|
× |
|
McLean-Harvard International First-Episode Project: Two-Year Stability of ICD-10 Diagnoses in 500 First-Episode Psychotic Disorder Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Novel Quality Control Metric for the Pharmacotherapy of Major Depressive Disorder: Measuring Guideline Concordance and Its Impact on Symptom Severity PDF |
$40.00 |
|
$40.00 |
|
× |
|
Paroxetine, Other Antidepressants, and Youth Suicide in New York City: 1993 Through 1998 PDF |
$40.00 |
|
$40.00 |
|
|
